QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fujita, H. Articles by Ohshima, K. Search for Related Content PubMed PubMed Citation Articles by Fujita, H. Articles by Ohshima, K.

---

Research Communication

Long-Term Ingestion of a Fermented Soybean-Derived Touchi-Extract with -Glucosidase Inhibitory Activity Is Safe and Effective in Humans with Borderline and Mild Type-2 Diabetes

Research and Development Department, Nippon Supplement, Incorporated., Kita-Ku, Osaka, 531-0076, Japan and ^* Ohshima Clinic, Ibaraki, Osaka, 567-0829, Japan

¹To whom correspondence should be addressed. E-mail: ngfh03{at}mail.nichigo.co.jp

Water-extracted Touchi, a traditional Chinese food, exerts a strong inhibitory activity against rat intestinal -glucosidase in foodstuffs, and Touchi-extract (TE) has been shown to have an antihyperglycemic effect in rats and humans after a single oral administration. In the present complementary study, the effects of powdered Houji-tea with or without (placebo) TE, a formula designed to enhance good compliance, were monitored in a 3-mo double-blind randomized group comparison study with placebo controls in humans with borderline and mild type-2 diabetes (n = 36). All subjects ingested Houji-tea with or without 0.3 g of TE before each of three meals per day for 3 mo. In the TE group, initial fasting blood glucose (6.9 ± 0.1 mmol/L) and glycated hemoglobin (HbA_1c; 6.1 ± 0.1%) levels gradually decreased; fasting blood glucose decreased significantly after 3 mo (6.4 ± 0.3 mmol/L; P < 0.05) as did HbA_1c (5.6 ± 0.2%; P < 0.01) levels at 2 mo postingestion of TE and thereafter. In contrast, fasting blood glucose and HbA_1c levels did not change in the placebo group. In this study, other biochemical variables were not affected in any of the subjects, and no one complained of any side effects or abdominal distension. Moreover, there was no deterioration as assessed by fasting blood glucose and HbA_1c levels after withdrawal of TE ingestion. Thus, the -glucosidase inhibitory TE demonstrated an antihyperglycemic effect and may prove useful for improving glycemic control in subjects suffering from borderline and type-2 diabetes mellitus.

KEY WORDS: • Touchi-extract • -glucosidase inhibitor • antiglycemic effect • type-2 noninsulin-dependent diabetes mellitus • humans

This article has been cited by other articles:

				F. A. van de Laar, P. L. Lucassen, R. P. Akkermans, E. H. van de Lisdonk, G. E. Rutten, and C. van Weel {alpha}-Glucosidase Inhibitors for Patients With Type 2 Diabetes: Results from a Cochrane systematic review and meta-analysis Diabetes Care, January 1, 2005; 28(1): 154 - 163. [Abstract] [Full Text] [PDF]

				H. Yajima, E. Ikeshima, M. Shiraki, T. Kanaya, D. Fujiwara, H. Odai, N. Tsuboyama-Kasaoka, O. Ezaki, S. Oikawa, and K. Kondo Isohumulones, Bitter Acids Derived from Hops, Activate Both Peroxisome Proliferator-activated Receptor {alpha} and {gamma} and Reduce Insulin Resistance J. Biol. Chem., August 6, 2004; 279(32): 33456 - 33462. [Abstract] [Full Text] [PDF]